Transgender patients in India, including 23-year-old activist Kali Sidharth Medepalli, report that their medical transition processes have been abruptly halted. Medepalli, who began hormone replacement therapy earlier this year with the expectation of completing surgical transition within a year, stated that her clinic ceased providing medication shortly after the Indian parliament passed amendments to the country's transgender legislation.

While the specific mechanism by which the law has impacted clinical operations remains under scrutiny, patients describe a sudden cessation of care. The situation has left many individuals in a state of medical limbo, unable to continue prescribed treatments or proceed with planned surgeries. The legislative changes appear to have created a climate of uncertainty for both patients and healthcare providers, leading to a widespread pause in services at facilities that previously offered gender-affirming care.

There is currently a lack of clarity regarding whether the clinics stopped services due to direct legal mandates or out of caution regarding the new regulatory environment. As patients like Medepalli seek to navigate these changes, the broader impact on the transgender community’s access to essential healthcare remains a significant concern for activists and medical professionals alike.